宣肺通腑法联合西药治疗慢性阻塞性肺疾病急性加重期患者的临床观察

目的观察宣肺通腑法联合西药治疗慢性阻塞性肺疾病急性加重期患者的效果。方法选取2012年10月～2013年10月北京市宣武中医医院的慢性阻塞性肺疾病急性加重期患者44例，将其分为两组，治疗组23例，对照组21例，对照组用常规西医治疗，治疗组在常规治疗的基础上加用宣肺通腑中药治疗。结果治疗组咳嗽、喘息、咳痰、便秘、腹胀治疗后效果优于对照组，差异有统计学意义（P〈0．05）。两组的呼吸功能指标[第1秒用力呼气容积占预计值的百分比（FEV1％pred）、FEV1／用力肺活量（FVC）1和血氧指标（动脉血氧分压、氧合指数）比较，差异有统计学意义（P〈0．05）。治疗组总体疗效明显优于对照组，差异有统计学意义（P〈0．05）。结论宣肺通腑法联合西药治疗慢性阻塞性肺疾病急性加重期效果优于单纯西药治疗。

Clinical observation of patients in COPD acute exacerbation by therapy of ventilating lung and relieving viscera combined with western medicine

Objective To observe the curative effect on patients in COPD acute exacerbation by therapy of ventilating lung and relieving viscera combined with western medicine. Methods 44 cases in COPD acute exacerbation treated in Beijing Xuanwu Hospital of Traditional Chinese Medicine from October 2010 to October 2013 were selected, with 23 cases in treatment group and 21 cases in control group. Patients in control group were treated with western medicine, while those in treatment group were given therapy of ventilating lung and relieving viscera combined with western medicine. Results The treatment effects in treatment group on coughing, pant, expectoration, constipation and abdomi- nal distention were significantly better than those in control group （P 〈 0.05）. The respiratory function indicators （FEV 1%pred, FEV1/FVC） and arterial oxygen indicators （arterial partial pressure of oxygen and oxygenation index） be- tween the two groups were significantly different （P 〈 0.05）. The overall effect of treatment group was significantly better than the control group （P 〈 0.05）. Conclusion The curative effect on patients in COPD acute exacerbation by therapy of ventilating lung and relieving viscera combined with western medicine is better than that of single western medicine.